Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

OpenAI’s contract clause could cut off Microsoft’s access to new AI models if AGI is declared, forcing high-stakes renegotiation of their partnership.

A key clause in Microsoft and OpenAI's deal embodies the raging divide between AGI true believers and those who think it's ...

Understanding protein motion is essential to understanding biology and advancing drug discovery,” said Nadella, in a post on ...

Microsoft is laying off thousands of employees, even as its profits and stock price hit historic highs. For many worried ...

Microsoft's new AI system, revealed by CEO Satya Nadella, surpasses human doctors in diagnosing complex medical cases, signaling a major step toward medical superintelligence.

Microsoft India partners with governments, as well as private and public institutions to develop cloud-based technological ...

Nvidia and Microsoft are making history as they reach a $4 trillion market cap, highlighting AI's transformative power and ...

Wedbush said Microsoft (MSFT) is next in line to the $4T market cap club, after Nvidia (NVDA) breached the mark on Wednesday, ...

Satya Nadella urges responsible AI energy use at Y Combinator event as Microsoft plans more layoffs amid a pivot to AI and ...